Northern Ireland pharmaceuticals group Galen Holdings is still interested in a merger which would extend its business worldwide.

Galen has not ruled out resuscitating the abandoned £1.5 billion merger with Dutch group, Ferring Pharmaceuticals, which was called off after the stock market slump.